Epigeneron
Latest round
- Series B
Last raised
- Mar 2021
Total raised
- $5.3M
Investors
- 3
About Epigeneron
Based in Tokyo, Japan, Epigeneron, Inc.Epigeneron, Inc. is engaged in developing biopharmaceutical products that target specific cellular pathways to enhance therapeutic efficacy.409 million.Epigeneron specializes in advanced biopharmaceutical solutions, focusing primarily on developing innovative therapies for various medical conditions. The company’s core product offerings include proprietary drug candidates designed to target specific cellular pathways, thereby enhancing therapeutic efficacy and reducing side effects. These products aim to address unmet medical needs in areas such as oncology, autoimmune diseases, and regenerative medicine. The end users of these products are primarily healthcare providers and patients seeking novel treatment options.Epigeneron generates revenue through a combination of direct sales and partnerships with healthcare institutions. The transaction structure typically involves B2B engagements, where healthcare providers procure the company’s therapeutics for use in patient care and clinical trials. Specific pricing plans for the products are determined based on the therapeutic indications and the complexity of the treatments offered. Flagship products may be sold under specialized contracts or licensing agreements, reflecting their innovative nature and the value they provide within the healthcare ecosystem.Epigeneron, Inc. The company is focused on designing and launching new products aimed at addressing critical healthcare needs, though specific release dates have not been disclosed. Epigeneron is also targeting expansion into new geographic markets in North America and Europe by 2023, aiming to increase its footprint and serve a larger patient population.
Who invested in Epigeneron
3 investors across 4 rounds
See all investors in Epigeneron
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Epigeneron
Who invested in Epigeneron?
Epigeneron has 3 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Epigeneron raised?
Epigeneron has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Epigeneron last raise money?
Epigeneron's most recent round on record is a Series B, in Mar 2021.
What does Epigeneron do?
Based in Tokyo, Japan, Epigeneron, Inc.
Where is Epigeneron headquartered?
Epigeneron is headquartered in Tokyo, Japan.
Which VCs invest in companies like Epigeneron?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Epigeneron's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Epigeneron? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.